- Report
- May 2024
- 40 Pages
Global
From €639EUR$695USD£543GBP
- Report
- February 2024
- 75 Pages
Global
From €4550EUR$4,950USD£3,869GBP
- Report
- January 2024
- 201 Pages
Global
From €4137EUR$4,500USD£3,517GBP
- Report
- October 2023
- 85 Pages
United States
From €4137EUR$4,500USD£3,517GBP
- Report
- August 2023
- 300 Pages
Latin America
From €4504EUR$4,900USD£3,830GBP
- Report
- August 2023
- 300 Pages
Asia Pacific
From €4504EUR$4,900USD£3,830GBP
- Report
- August 2023
- 300 Pages
Europe
From €4504EUR$4,900USD£3,830GBP
- Report
- August 2023
- 300 Pages
Middle East, Africa
From €4504EUR$4,900USD£3,830GBP
- Report
- August 2023
- 1350 Pages
Global
From €8181EUR$8,900USD£6,956GBP
- Report
- August 2023
- 51 Pages
India
From €552EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Argentina
From €552EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
South Korea
From €552EUR$600USD£469GBP
From €552EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
South Africa
From €552EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Australia
From €552EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Japan
From €552EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Saudi Arabia
From €552EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Israel
From €552EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Colombia
From €552EUR$600USD£469GBP
- Report
- August 2023
- 51 Pages
Canada
From €552EUR$600USD£469GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more